Results 121 to 130 of about 900 (164)
Some of the next articles are maybe not open access.

Congenital dysfibrinogenemia

Current Opinion in Hematology, 1997
Fibrinogen abnormalities can be classified as congenital or acquired. Each class manifests quantitative or qualitative alterations; the latter are known as dysfibrinogenemias. In dysfibrinogenemias, structural defects cause alterations in the conversion of fibrinogen to fibrin.
openaire   +2 more sources

Sneddon Syndrome revealing dysfibrinogenemia

International Journal of Dermatology, 2003
Sneddon syndrome (SS) is the association of cerebral ischemic events and livedo and is caused by vascular thrombosis. It is often associated with a primitive antiphospholipid syndrome (PAPS). In other cases, several thrombophilic conditions have been implicated. Dysfibrinogenemia is a qualitative defect of fibrinogen.
Khosrotehrani, Kiarash   +4 more
openaire   +5 more sources

A Hereditary Dysfibrinogenemia: Fibrinogen Awaji

Haemostasis, 2009
Abnormal function of fibrinogen was observed in a 2 5-year-old woman with no symptoms attributable to dysfibrinogenemia. Disturbed polymerization of fibrin monomer was identified, but the release of fibrinopeptide from the purified fibrinogen and the cross-linking by factor XIII were normal.
T, Matsuo   +5 more
openaire   +2 more sources

Dysfibrinogenemia in Obstructive Liver Disease

Journal of Pediatric Gastroenterology and Nutrition, 1987
SummaryAcquired dysfibrinogenemia was documented in a 4‐year‐old child with obstructive jaundice of 1‐month duration, secondary to a choledochal cyst involving the distal common bile duct. It was characterized by decreased thrombin coagulable protein with elevated immunoassayable fibrinogen resulting in abnormal thrombin and reptilase times.
J, Levy, M J, Pettei, J I, Weitz
openaire   +2 more sources

Congenital dysfibrinogenemia : Fibrinogen lille

Thrombosis Research, 1978
A dysfibrinogenemia (fibrinogen Lille) was detected in a 6 year old girl with no history of unusual bleeding. Thrombin and batroxobin (“reptilase”) times were markedly prolonged. The plasma fibrinogen level was unmeasurable by a kinetic method (Clauss), whereas normal values were obtained by immunochemical (Laurell) and gravimetric (Ingram) assays ...
M H, Denninger   +5 more
openaire   +2 more sources

Management of pregnancy in dysfibrinogenemia cases

Blood Coagulation & Fibrinolysis, 2017
Dysfibrinogenemia is a very challenging disorder, and there are no firm guidelines on treatment for pregnant patients with dysfibrinogenemia. A 37-year-old patient with a history of six unexplained recurrent miscarriages was referred for thrombophilia testing.
Rucha, Patil   +3 more
openaire   +2 more sources

Dysfibrinogenemia and thrombosis.

Nouvelle revue francaise d'hematologie, 1992
A thrombotic tendency (venous or arterial) has been reported in some cases of dysfibrinogenemia. We report here the mechanism by which these thrombosis may occur. It may be related either to a defective clot lysis due to a poor reactivity toward fibrinolytic enzymes or to a defective thrombin binding capacity of the abnormal clot.
J, Soria   +5 more
openaire   +1 more source

Congenital Dysfibrinogenemias

Annals of Internal Medicine, 1972
H R, Gralnick, J S, Finlayson
openaire   +2 more sources

[Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl)].

Klinische Wochenschrift, 1977
A new case of dysfibrinogenemia is reported which shows no signs of a haermorrhagic diathesis (dysfibrinogenemia Giessen III). The abnormal fibrinogen was detected by only slight but characteristic alterations of some parameter of the coagulation analysis (prolonged clotting times after addition of thrombin, Reptilase and thrombin coagulase; low ...
F R, Matthias   +4 more
openaire   +1 more source

Dysfibrinogenemia and placental abruption

Obstetrics & Gynecology, 2000
R Z, Edwards, A, Rijhsinghani
openaire   +2 more sources

Home - About - Disclaimer - Privacy